BioXyTran
Newton, United States· Est. 2014
BioXyTran Inc. is a biopharmaceutical company focused on developing anti-necrosis treatment for stroke and ischemia.
Private Company
Total funding raised: $6.5M
About
BioXyTran Inc. is a biopharmaceutical company focused on developing anti-necrosis treatment for stroke and ischemia.
Biologics
Funding History
2Total raised:$6.5M
Series A$5MMar 15, 2022
Seed$1.5MJun 15, 2021